Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Phagocytosis and Immune Regulation, and Lung Cancer Treatments and Mutations.
The new idea of cancer immunotherapy: the expression of PD-L1 may reveal the immunological mechanism of resistance of EGFR-TKIs
Expression and prognostic analysis of CLDN18 and Claudin18.2 in lung adenocarcinoma
Prognostic implications of stromal tumor-infiltrating lymphocytes and programmed death ligand 1 expression in HER2-positive invasive breast cancer
[Lung adenocarcinoma with epidermal growth factor receptor mutation transferred to the oral cavity: a report of two cases].
Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
MAGE‐A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer
MAGE-A family is involved in gastric cancer progression and indicates poor prognosis of gastric cancer patients
Zebularine Treatment Induces MAGE-A11 Expression and Improves CTL Cytotoxicity Using a Novel Identified HLA-A2-restricted MAGE-A11 Peptide
Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63
MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray
Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA Microarray